drugset / Trial / NCT03021018
A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy of intravenous brivaracetam (BRV) compared to intravenous lorazepam (LZP) in subjects with epilepsy undergoing Epilepsy Monitoring Unit (EMU) evaluation who experience seizures that require prompt treatment.
Timeline
- Start
- 2017-02-06
- Primary completion
- 2018-04-27
- Completion
- 2018-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivaracetam | Small molecule | 100 mg | Intravenous |
| Subject | Brivaracetam | Small molecule | 200 mg | Intravenous |
| Comparator | Lorazepam | Small molecule | — | Intravenous |